Altimmune, Inc. (ALT)
3.505
-0.74
(-17.53%)
USD |
NASDAQ |
Mar 05, 16:00
3.64
+0.14
(+3.85%)
After-Hours: 20:00
Altimmune Cash from Investing (TTM) : -39.68M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Amgen, Inc. | -1.943B |
| Eli Lilly & Co. | -10.97B |
| Viking Therapeutics, Inc. | 341.39M |
| CorMedix, Inc. | -312.03M |
| Actinium Pharmaceuticals, Inc. | 0.00 |